On Friday morning, June 21 (6:30–7:15 a.m. in the West Building, Level 1), VAM 2024 attendees will have the chance to take in an International Fast Talk scientific session featuring updates on the latest devices, studies and procedural techniques from all over the globe, and across the full gamut of vascular surgery—including venous stenting, aortic remodeling, dialysis access creation, carotid aneurysm management, and much more.
“The abstracts highlighted in this international session are extremely diverse, including multicentered clinical trials, original research and innovative techniques from around the world,” said Wei Zhou, MD, professor of Surgery at the University of Arizona in Tucson, who is among the session’s moderators.
The session will kick off with a presentation on the safety and effectiveness of the single Prostyle (Abbott) vascular pre-close technique in patients undergoing endovascular procedures. Presenting author Rocco Cangiano, MD, vascular surgery resident at the Sapienza University of Rome in Italy, will deliver findings from a single-center, prospective study that indicate the technique’s efficacy and safety in selected vascular accesses.
Additional European perspectives will be highlighted during the session, as Jerome Albertin, vascular surgeon at Polytechnic Notre Dame in Draguignan, France, presents positive 12-month ELLIPSE study results regarding the treatment of femoropopliteal lesions using the Jetstream atherectomy device and Ranger drugcoated balloon (both Boston Scientific).
And, later, maintaining the thread of endovascular topics, Pasqualino Sirignano, MD, associate professor of vascular surgery at the Sapienza University of Rome, will present insights from SAFEEVAR—a Delphi questionnaire-based study that sought to elucidate the attitude of Italian vascular surgeons towards the use of standard endovascular aneurysm repair (EVAR) to treat infrarenal abdominal aortic aneurysms (AAAs) outside the current instructions for use (IFU).
Venous stenting is also on the agenda, with Mahmood Razavi, MD, director of the Clinical Trials and Research Center at St. Joseph Vascular Institute in Orange, California, set to present the VIVID clinical trial and discuss outcomes with the Duo (Vesper Medical/Philips) stent system.
Lixin Wang, MD, deputy director of Zhongshan Hospital affiliated with Fudan University in Shanghai, China, will outline a study that aimed to compare aortic remodeling of the distal aorta after traditional thoracic EVAR (TEVAR) against repair with the Fabulous (Hangzhou Endonom Medtech) stent—a new, two-stage stent system based on the PETTICOAT technique—in type B aortic dissection (TBAD) patients. The session will also see International Achievement Award recipient Chun Che Shih, MD, deputy superintendent of Taipei Wanfang Hospital in Taipei, Taiwan, provide insights from his lifelong work on aortic dissection. Later in the session, TBAD will come into focus again, as Besher Tolaymat, MD, integrated vascular surgery resident at Cooper University Hospital in Camden, New Jersey, delivers findings from a systematic review assessing the available literature on the variability of impulse control management in these cases.
Elsewhere, a potential innovation in hemodialysis access is set to be presented. Hsuan Yu Chen, from China Medical University Hospital in Taichung, Taiwan, will describe the creation of an “artificial aneurysm” over the brachial artery as an alternative to traditional “shuntless” access approaches.
The carotid territory will also feature—initially, with insights from the prospective, multicenter, international Carotid Aneurysm Registry (CAR) on the conservative management of extracranial carotid artery aneurysms by Saskia I. Willemsen, a PhD student at UMC Utrecht in The Netherlands.
